论文部分内容阅读
目的：探讨ＬＡＫ细胞／ＩＬ－２对癌性胸、腹水的治疗效果。方法：２１例癌性胸、腹水患者用ＬＡＫ细胞／ＩＬ－２直接灌注治疗，每周２次，连续２～３周。结果：治疗有效率为７６．２％，患者一般症状明显改善，免疫状态增强，治疗副作用为一过性发热。结论：ＬＡＫ细胞／ＩＬ－２直接胸、腹腔灌注是治疗癌性胸、腹水的有效手段
Objective: To investigate the therapeutic effect of LAK cells/IL-2 on cancerous thoracic and ascites. METHODS: Twenty-one patients with cancerous thoracic and ascites were treated with direct infusion of LAK cells/IL-2 twice a week for 2 to 3 weeks. Results: The effective rate of treatment was 76.2%. The patient’s general symptoms improved significantly and the immune status increased. The side effects of treatment were transient fever. Conclusion: Direct thoracic and intraperitoneal perfusion of LAK cells/IL-2 is an effective method to treat cancerous thoracic and ascites